Neuroendocrine Differentiation in Prostate Cancer: From Lab to Bedside

Publisher： Karger

E-ISSN： 1423-0399|79|4|287-296

ISSN： 0042-1138

Source： Urologia Internationalis, Vol.79, Iss.4, 2007-11, pp. : 287-296

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Molecular pathology and prostate cancer therapeutics: from biology to bedside

By  

THE JOURNAL OF PATHOLOGY, Vol. 232, Iss. 2, 2014-01 ,pp. : 178-184

John Wiley & Sons Inc

Access to resources Recommend Favorite

Elevated circulating tissue inhibitor of metalloproteinase 1 (TIMP‐1) levels are associated with neuroendocrine differentiation in castration resistant prostate cancer

By  

THE PROSTATE, Vol. 75, Iss. 6, 2015-05 ,pp. : 616-627

John Wiley & Sons Inc

Access to resources Recommend Favorite

Transforming growth factor‐β signaling induced during prostate cancer cell death and neuroendocrine differentiation is mediated by bone marrow stromal cells

By  

THE PROSTATE, Vol. 75, Iss. 15, 2015-11 ,pp. : 1802-1813

John Wiley & Sons Inc

Access to resources Recommend Favorite

Transforming growth factor‐β signaling induced during prostate cancer cell death and neuroendocrine differentiation is mediated by bone marrow stromal cells

By  

THE PROSTATE, Vol. 270-4137, Iss. 15, 2015-11 ,pp. : 1802-1813

John Wiley & Sons Inc

Access to resources Recommend Favorite

Small Cell/Neuroendocrine Carcinoma May Be a More Common Phenotype in Advanced Prostate Cancer

By  

Urologia Internationalis, Vol. 69, Iss. 2, 2002-08 ,pp. : 166-168

Karger

Access to resources Recommend Favorite